Health3 AG vs SureThing.io

Health3 AG is an innovative health technology platform designed to solve a common and frustrating problem: the confusion of standard blood lab reports. For health-conscious individuals, people managing chronic conditions, or anyone seeking to optimize their wellness, paper lab results are often just a list of isolated numbers and medical jargon. Health3 transforms this static, confusing data into a dynamic, actionable roadmap for your health. The core value proposition is its ability to instantly digitize your paper reports via a simple photo scan and then go far beyond simple data storage. It analyzes your biomarkers not in isolation, but by revealing their intricate relationships and combined impact on specific health areas like energy, metabolism, immunity, and sleep quality. This allows you to move from guessing what your results mean to making informed, targeted decisions to improve your overall well-being. Health3 empowers you to understand the complete picture of your biology, identify potential root causes of issues, and track your progress toward better health.

SureThing is an autonomous AI agent that remembers who you are and works on your behalf 24/7. Unlike AI chatbots that wait for instructions, SureThing operates proactively: it monitors your inbox, drafts replies in your voice, manages your schedule, tracks ongoing projects, and takes action across connected apps while you're focused elsewhere.
Its persistent memory sets it apart — SureThing remembers your preferences, your patterns, your contacts, and your goals across every session. It doesn't lose context, doesn't repeat mistakes, and adapts continuously to how you work.
SureThing is built for reliability over demos. SOC 2 certified and Google CASA Tier 2 compliant, it is designed for users who need an agent they can actually trust with real work — not one that breaks the moment it leaves the slide deck.
Early adopters include a technical director who contributed code to OpenClaw and calls SureThing "the Mac of AI agents," and solo founders executing full go-to-market launches alone.